<DOC>
	<DOCNO>NCT00905164</DOCNO>
	<brief_summary>The objective study compare rate extent absorption topiramate 25 mg capsule ( test ) versus Topamax® ( reference ) administer 2 x 25 mg capsule fast condition .</brief_summary>
	<brief_title>Topiramate 25 mg Capsules Under Fasting Conditions</brief_title>
	<detailed_description>Criteria Evaluation : FDA Bioequivalence Criteria Statistical Methods : FDA bioequivalence statistical method</detailed_description>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Subjects females and/or male , nonsmoker , 18 year age old Subjects read , sign date Informed Consent Form prior study procedure . Female subject postmenopausal surgically sterilize . Post menopausal status define absence menses past 12 month bilateral oophorectomy least 6 month ago hysterectomy bilateral oophorectomy least 6 month ago . Sterile status define hysterectomy , bilateral oophorectomy tubal ligation aat least 6 month ago . Clinically significant illness within 4 week administration study medication . Clinically significant surgery within 4 week prior administration study medication . Any history presence significant neurological , hepatic , renal , endocrinal , cardiovascular , pulmonary , hematologic , immunologic , psychiatric metabolic disease . Any clinically significant abnormality find medical screening . Abnormal laboratory test judge clinically significant . Positive urine drug screen screen . Positive alcohol breath test screening . Subjects use tobacco form eligible participate study . Three month abstinence require . Positive test hepatitis B , hepatitis C HIV screen . ECG vital sign abnormality ( clinically significant ) . Subjects BMI great equal 30.0 . History significant alcohol abuse within 6 month screen visit indication regular use two unit alcohol per day ( 1 Unit = 150 mL wine 360 mL beer 45 mL alcohol 40 % ) . History drug abuse use illegal drug : use soft drug ( marijuana ) within 3 month screen visit hard drug ( cocaine , phencyclidine ( PCP ) crack ) within 1 year screen visit . Any food allergy , intolerance , restriction special diet , opinion medical subinvestigator , contraindicate subject participation study . History allergic reaction topiramate . Use drug know induce inhibit hepatic drug metabolism , use investigational drug participation investigational study within 30 day prior administration study medication . Use prescription medication within 14 day prior administration study medication overthecounter product within 7 day prior administration study medication , except topical product without systemic absorption . Donation plasma ( 500 mL ) within 7 day donation significant loss whole blood ( 500 mL ) within 56 day prior administration study medication . Any reason , opinion medical subinvestigator , would prevent subject participate study . Additional exclusion criterion female : • Positive urine pregnancy test screening ( performed female ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>